thyrotoxicosis syndrome Medical sheet with answers

Reading File
Reading File
Reading File
Searching the Web

thyrotoxicosis diagnosis management guideline thyroid storm ATA

Finding Sources
Searching PubMed

"Thyrotoxicosis"[MeSH Terms] AND management

Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources

Thyrotoxicosis Syndrome - Medical Sheet With Answers

1. Definition

Thyrotoxicosis is the clinical syndrome caused by excess circulating thyroid hormones, T3 and/or T4, producing a hypermetabolic and hyperadrenergic state.
Hyperthyroidism is a subset of thyrotoxicosis caused by increased synthesis and secretion of thyroid hormone by the thyroid gland.
  • Hyperthyroidism always causes thyrotoxicosis.
  • Thyrotoxicosis may occur without hyperthyroidism, for example in thyroiditis or excess levothyroxine ingestion.
Textbook reference: Textbook of Family Medicine 9e, pp. 162-168.

2. Causes

MechanismImportant causes
Increased hormone synthesisGraves disease, toxic multinodular goiter, toxic adenoma, TSH-secreting pituitary adenoma
Release of preformed hormoneSubacute thyroiditis, painless/silent thyroiditis, postpartum thyroiditis, amiodarone-induced destructive thyroiditis
Exogenous thyroid hormoneExcess levothyroxine, factitious thyrotoxicosis
Other sourcesStruma ovarii, iodine-induced thyrotoxicosis
Most common cause: Graves disease.

3. Clinical Features

Symptoms

  • Weight loss despite increased appetite
  • Heat intolerance and excessive sweating
  • Palpitations
  • Tremor, nervousness, anxiety, irritability
  • Fatigue and proximal muscle weakness
  • Increased bowel frequency or diarrhea
  • Menstrual disturbance, reduced fertility
  • Reduced libido
  • Hair thinning

Signs

  • Tachycardia, widened pulse pressure, systolic flow murmur
  • Fine tremor of outstretched hands
  • Warm, moist skin
  • Hyperreflexia
  • Goiter
  • Atrial fibrillation, particularly in older adults
  • Proximal myopathy
  • Lid lag or lid retraction

Features pointing to Graves disease

  • Diffuse, often vascular goiter with bruit
  • Graves orbitopathy: proptosis, diplopia, periorbital edema
  • Pretibial myxedema
  • Thyroid acropachy, rarely
Older adults may present atypically with lethargy, weight loss, heart failure, atrial fibrillation, or depression-like symptoms, called apathetic thyrotoxicosis.
Textbook reference: Textbook of Family Medicine 9e, pp. 164-178.

4. Investigations

A. Confirm biochemical thyrotoxicosis

TestTypical finding
TSHSuppressed or undetectable
Free T4 and free T3Elevated
T3 toxicosisSuppressed TSH, high T3, normal free T4
Subclinical hyperthyroidismLow TSH with normal free T4 and T3

B. Establish the cause

TestInterpretation
TSH-receptor antibody, TRAb/TSIPositive supports Graves disease
Radioactive iodine uptake scanDiffuse increased uptake: Graves; focal uptake: toxic adenoma; patchy uptake: toxic multinodular goiter; low uptake: thyroiditis, exogenous hormone, iodine excess
Thyroid Doppler ultrasoundIncreased diffuse vascularity supports Graves disease; useful where uptake scan is unsuitable
ESR/CRPOften elevated in painful subacute thyroiditis
ThyroglobulinLow in factitious/exogenous hormone intake; usually raised with endogenous hormone release
ECGSinus tachycardia or atrial fibrillation
Do not perform radioactive iodine uptake testing during pregnancy or breastfeeding.

5. Distinguishing Common Causes

FeatureGraves diseaseToxic nodular goiter/adenomaThyroiditisExogenous thyroid hormone
GoiterDiffuseNodularMay be small or tenderUsually absent
Eye signsMay occurNoNoNo
TRAbOften positiveNegativeNegativeNegative
Radioiodine uptakeDiffuse highFocal or patchy highLowLow
Main treatmentAntithyroid drug, radioiodine, or surgeryRadioiodine or surgerySymptomatic treatmentStop/reduce hormone

6. General Management

Symptom control

A beta-blocker is used for tremor, anxiety, palpitations, and tachycardia, unless contraindicated.
  • Propranolol is commonly used.
  • A cardioselective beta-blocker may be considered when appropriate.
  • Avoid or use specialist advice in decompensated heart failure, marked bradycardia, shock, or severe bronchospasm.
Symptomatic treatment should begin promptly and should not wait for completion of etiologic testing.
Textbook reference: Textbook of Family Medicine 9e, p. 168.

Definitive treatment for hyperthyroidism

Choice depends on cause, age, goiter size, pregnancy status, orbitopathy, patient preference, and comorbidities.
  1. Antithyroid drugs
    • Methimazole/carbimazole is usually preferred.
    • Propylthiouracil, PTU, is preferred in:
      • First trimester of pregnancy
      • Thyroid storm
    • Important adverse effects:
      • Rash, pruritus, arthralgia
      • Agranulocytosis
      • Hepatotoxicity, particularly with PTU
Patient safety instruction: Stop the antithyroid drug and obtain an urgent full blood count if fever, sore throat, mouth ulcers, or other infection symptoms occur.
  1. Radioactive iodine, I-131
    • Definitive treatment for Graves disease and toxic nodular disease.
    • May result in permanent hypothyroidism requiring levothyroxine.
    • Contraindicated in pregnancy and breastfeeding.
    • Can worsen Graves orbitopathy in some patients.
  2. Thyroidectomy
    • Consider for large goiter/compressive symptoms, suspected cancer, severe orbitopathy, need for rapid definitive treatment, or when medication/radioiodine is unsuitable.
The three main methods for controlling hyperthyroidism are antithyroid medication, radioactive iodine ablation, and thyroidectomy. Lippincott Illustrated Reviews: Pharmacology, p. 783. The ATA thyrotoxicosis guideline provides etiology-specific recommendations.

7. Thyrotoxicosis Without Hyperthyroidism

Antithyroid drugs do not correct thyrotoxicosis caused by release of stored hormone or exogenous hormone intake.
CauseMain management
Subacute thyroiditisBeta-blocker; NSAID for pain; glucocorticoid in severe painful cases
Painless/postpartum thyroiditisBeta-blocker; monitor for later hypothyroidism
Factitious thyrotoxicosisStop/reduce exogenous thyroid hormone; assess cause safely
Iodine- or amiodarone-related diseaseEndocrinology-directed treatment according to subtype

8. Thyroid Storm

Definition

Thyroid storm is an acute, life-threatening decompensation of severe thyrotoxicosis with systemic organ dysfunction.

Precipitating factors

  • Infection
  • Surgery or trauma
  • Myocardial infarction or heart failure
  • Diabetic ketoacidosis
  • Pulmonary embolism
  • Labor/delivery
  • Abrupt withdrawal or non-adherence to antithyroid drugs
  • Iodine exposure or, occasionally, radioiodine treatment

Clinical features

  • High fever
  • Marked tachycardia or atrial fibrillation
  • Agitation, delirium, psychosis, seizure, or coma
  • Vomiting, diarrhea, abdominal pain
  • Jaundice or hepatic dysfunction
  • Heart failure, shock, pulmonary edema

Emergency treatment principles

This requires emergency hospital treatment, generally in an ICU or high-dependency setting.
  1. Resuscitation and supportive care
    • Oxygen, IV fluids as clinically appropriate, cooling, cardiac monitoring
    • Treat trigger, especially infection
    • Use paracetamol/acetaminophen for fever. Avoid aspirin because it can increase free thyroid hormone.
  2. Beta-blockade
    • To control adrenergic manifestations, if hemodynamically safe.
  3. Thionamide
    • PTU is often selected because it reduces new hormone synthesis and also inhibits peripheral T4-to-T3 conversion.
    • Methimazole is an alternative in relevant situations.
  4. Iodine
    • Give only after a thionamide, usually at least 1 hour later, to block hormone release.
  5. Glucocorticoid
    • Reduces peripheral conversion of T4 to T3 and addresses possible relative adrenal insufficiency.
  6. Consider additional measures
    • Cholestyramine, plasma exchange, or urgent thyroidectomy in refractory cases with specialist input.
The order matters: iodine should follow thionamide therapy, not precede it. Rosen's Emergency Medicine, Management of Thyrotoxicosis, pp. 135-168. Thyroid storm has reported mortality of roughly 8% to 25%. Tintinalli's Emergency Medicine, p. 1491.

Short Answer Questions With Answers

Q1. Define thyrotoxicosis.

Answer: A clinical syndrome due to excess circulating T3 and/or T4 causing hypermetabolism and hyperadrenergic manifestations. It may occur with or without increased thyroid hormone synthesis.

Q2. What is the difference between thyrotoxicosis and hyperthyroidism?

Answer: Hyperthyroidism means increased thyroid hormone synthesis by the gland. Thyrotoxicosis means thyroid hormone excess from any cause, including thyroiditis and exogenous hormone ingestion.

Q3. Name the most common cause of thyrotoxicosis.

Answer: Graves disease.

Q4. What are the cardinal biochemical findings in primary thyrotoxicosis?

Answer: Suppressed TSH with elevated free T4 and/or free T3.

Q5. What is T3 toxicosis?

Answer: Suppressed TSH and elevated T3 with normal free T4.

Q6. Which antibody supports a diagnosis of Graves disease?

Answer: TSH-receptor antibody, TRAb, also termed thyroid-stimulating immunoglobulin, TSI.

Q7. What scan pattern is seen in Graves disease?

Answer: Diffusely increased radioactive iodine uptake.

Q8. What scan pattern is seen in thyroiditis?

Answer: Low radioactive iodine uptake.

Q9. State three common features of Graves orbitopathy.

Answer: Proptosis, diplopia, and periorbital edema. Lid retraction and lid lag are also frequent.

Q10. What is the usual first drug for symptom relief in thyrotoxicosis?

Answer: A beta-blocker, commonly propranolol if not contraindicated.

Q11. What are the three main definitive therapies for hyperthyroidism?

Answer: Antithyroid drugs, radioactive iodine, and thyroidectomy.

Q12. Which antithyroid drug is generally preferred for routine treatment?

Answer: Methimazole or carbimazole, depending on local availability.

Q13. When is PTU preferred?

Answer: In thyroid storm and during the first trimester of pregnancy.

Q14. Name two serious adverse effects of thionamides.

Answer: Agranulocytosis and hepatotoxicity.

Q15. What should a patient taking methimazole/carbimazole/PTU do if fever or sore throat develops?

Answer: Stop the drug and seek urgent medical evaluation with a full blood count to exclude agranulocytosis.

Q16. Why are antithyroid drugs not useful in destructive thyroiditis?

Answer: The problem is release of preformed hormone rather than new hormone synthesis.

Q17. What is thyroid storm?

Answer: Life-threatening severe thyrotoxicosis with systemic decompensation, such as hyperthermia, CNS disturbance, cardiovascular failure, or hepatic/GI dysfunction.

Q18. State the medication sequence in thyroid storm.

Answer: Beta-blocker if appropriate, thionamide, then iodine at least 1 hour later, plus glucocorticoid and supportive/trigger-directed treatment.

Q19. Why should aspirin be avoided for fever in thyroid storm?

Answer: It can displace thyroid hormone from binding proteins and increase free hormone levels.

Q20. List four triggers for thyroid storm.

Answer: Infection, surgery/trauma, stopping antithyroid drugs, myocardial infarction, diabetic ketoacidosis, labor, or iodinated contrast exposure.

Emergency Warning

Urgent emergency assessment is needed for a person with possible thyrotoxicosis plus high fever, confusion, severe agitation, fainting, chest pain, breathlessness, persistent rapid heartbeat, jaundice, or heart failure symptoms because thyroid storm can develop.
Recent evidence includes systematic reviews on drug treatment and complex perioperative cases, but these do not replace cause-specific specialist management. Relevant reviews: PMID 41623375 and PMID 39722810.

In the form of medical sheet of a patient

Reading File
Searching the Web

thyrotoxicosis clinical assessment diagnosis treatment American Thyroid Association guidelines

Searching PubMed

"Thyrotoxicosis"[MeSH Terms] AND management

Finding Sources

Medical Patient Sheet: Thyrotoxicosis Syndrome

This is a sample completed clinical case sheet for study purposes.

Patient Identification

  • Name: Ms. A.B.
  • Age/Sex: 28 years/Female
  • Date of admission: __________
  • Hospital number: __________
  • Informant: Patient
  • Reliability: Reliable

Chief Complaints

  1. Palpitations for 2 months
  2. Weight loss despite increased appetite for 2 months
  3. Excessive sweating and heat intolerance for 6 weeks
  4. Tremulousness, irritability, and anxiety for 1 month
  5. Prominence of both eyes for 3 weeks

History of Present Illness

The patient was apparently well 2 months ago, when she developed gradual-onset palpitations. The palpitations are persistent, rapid, and worsened by exertion. They are associated with sweating, heat intolerance, nervousness, fine tremors of both hands, easy fatigability, and difficulty sleeping.
She reports an increased appetite but has lost approximately 6 kg over 2 months. There is increased frequency of bowel movements, about 3 to 4 times per day, without blood or mucus. She also reports reduced menstrual flow over the past two cycles.
She noticed painless swelling in the front of her neck 1 month ago, which has gradually increased in size. There is no neck pain, dysphagia, hoarseness, or dyspnea. For the last 3 weeks, she has noticed prominence of both eyes, excessive tearing, and a gritty sensation.
There is no history of fever, sore throat, vomiting, diarrhea, chest pain, syncope, or altered sensorium. No history of recent iodinated contrast exposure or use of amiodarone. No history of excess intake of levothyroxine or weight-loss preparations.

Past History

  • No known diabetes mellitus, hypertension, tuberculosis, asthma, or heart disease.
  • No prior thyroid disease or thyroid surgery.
  • No previous hospitalization.

Drug History

  • Not taking levothyroxine, amiodarone, lithium, or herbal thyroid preparations.
  • No known drug allergies.

Family History

  • Mother has a history of autoimmune thyroid disease.
  • No family history of thyroid cancer.

Personal History

  • Appetite: Increased
  • Diet: Mixed
  • Bowel: Increased frequency
  • Bladder: Normal
  • Sleep: Disturbed
  • Menstrual history: Oligomenorrhea
  • Smoking/alcohol: No

Examination

General Physical Examination

ParameterFinding
General conditionConscious, cooperative, anxious-looking
Build/nutritionThin-built
Pulse112/min, regular, high volume
Blood pressure140/60 mmHg
Respiratory rate18/min
TemperatureAfebrile
PallorAbsent
IcterusAbsent
CyanosisAbsent
ClubbingAbsent
Pedal edemaAbsent
Lymph nodesNot enlarged

General Signs of Thyrotoxicosis

  • Fine tremor of outstretched hands present
  • Warm, moist palms
  • Hyperreflexia present
  • Proximal muscle weakness present
  • Hair is fine and may be diffusely thinned

Thyroid Examination

Inspection

  • Diffuse swelling in the anterior neck, moving with deglutition.
  • No scar, sinus, or visible venous prominence.

Palpation

  • Thyroid diffusely enlarged, soft, non-tender.
  • No discrete nodules.
  • Lower border palpable.
  • No cervical lymphadenopathy.
  • Thrill may be present.

Auscultation

  • Thyroid bruit may be heard over each lobe.
Interpretation: Diffuse toxic goiter, suggestive of Graves disease.

Eye Examination

  • Bilateral lid retraction and lid lag
  • Mild bilateral proptosis
  • Periorbital edema absent or mild
  • Extraocular movements normal
  • No diplopia
  • Visual acuity normal
Interpretation: Mild Graves orbitopathy.

Systemic Examination

Cardiovascular System

  • Tachycardia present
  • Hyperdynamic precordium
  • S1 and S2 audible
  • No murmur
  • No features of heart failure

Respiratory System

  • Bilateral air entry present
  • No crepitations

Central Nervous System

  • Higher mental functions normal
  • Fine tremor and brisk reflexes present
  • No focal neurological deficit

Abdomen

  • Soft, non-tender
  • No hepatosplenomegaly

Provisional Diagnosis

Thyrotoxicosis due to Graves disease with diffuse goiter and mild Graves orbitopathy.

Differential Diagnosis

  1. Toxic multinodular goiter
  2. Toxic adenoma
  3. Painless or subacute thyroiditis
  4. Exogenous thyroid hormone intake, factitious thyrotoxicosis
  5. Iodine-induced thyrotoxicosis
  6. TSH-secreting pituitary adenoma, less likely

Investigations

Thyroid Function Tests

InvestigationResultInterpretation
TSH<0.01 mIU/LSuppressed
Free T4ElevatedThyrotoxicosis
Free T3ElevatedThyrotoxicosis
TSH receptor antibody, TRAbPositiveSupports Graves disease
Anti-TPO antibodyMay be positiveAutoimmune thyroid disease

Other Investigations

TestExpected result / purpose
CBC with differential countBaseline before antithyroid drug therapy
Liver function testsBaseline before thionamide therapy
Renal function testsBaseline assessment
Blood glucoseTo assess metabolic status
ECGSinus tachycardia or possible atrial fibrillation
Thyroid ultrasound with DopplerDiffuse enlargement and increased vascularity
Radioactive iodine uptake scanDiffusely increased uptake in Graves disease
Pregnancy testRequired in women of childbearing potential before radioactive iodine consideration
Note: Radioactive iodine uptake scanning is contraindicated in pregnancy and breastfeeding.

Final Diagnosis

Graves disease causing overt thyrotoxicosis, with diffuse toxic goiter and mild Graves orbitopathy.
The diagnosis is supported by suppressed TSH, elevated free T4/T3, diffuse goiter, eye signs, positive TRAb, and diffuse increased uptake on thyroid scan.

Management Plan

1. Symptomatic Treatment

  • Beta-blocker for palpitations, tremor, and anxiety, if no contraindication.
    • Example: propranolol, prescribed and monitored by the treating clinician.
  • Monitor pulse, blood pressure, ECG, and symptoms.

2. Antithyroid Drug Therapy

  • Methimazole/carbimazole is usually preferred for routine Graves disease.
  • PTU is preferred in:
    • First trimester of pregnancy
    • Thyroid storm

Patient Counseling Before Starting Thionamide

The patient must be told to stop the drug and seek urgent medical care if any of the following occur:
  • Fever
  • Sore throat
  • Mouth ulcers
  • Jaundice
  • Dark urine
  • Severe itching or rash
  • Persistent nausea/vomiting
These may indicate rare but serious adverse effects such as agranulocytosis or hepatotoxicity.

3. Definitive Treatment Options

Discuss after stabilizing thyrotoxicosis:
OptionComments
Antithyroid drug courseMay achieve remission in Graves disease
Radioactive iodineEffective but may cause permanent hypothyroidism; avoid in pregnancy/breastfeeding and consider eye disease
ThyroidectomyConsider for large goiter, compressive symptoms, suspected malignancy, severe orbitopathy, or need for rapid definitive treatment

4. Eye Care

  • Refer to ophthalmology if eye symptoms are significant.
  • Advise smoking cessation, if applicable, because smoking worsens Graves orbitopathy.
  • Lubricating eye drops may help gritty sensation.
  • Urgent ophthalmology assessment for reduced vision, color vision changes, pain, or diplopia.

5. Follow-up

  • Review clinical symptoms, pulse, weight, free T4, free T3, and TSH regularly.
  • Early monitoring is guided mainly by free T4/T3, because TSH can remain suppressed for some time.
  • Repeat CBC/LFTs if symptoms suggest toxicity.
The American Thyroid Association guidance recognizes antithyroid drugs, radioactive iodine, and surgery as the principal treatment approaches, selected according to etiology and patient-specific factors.

Danger Signs: Rule Out Thyroid Storm

Monitor for:
  • Fever
  • Severe persistent tachycardia or atrial fibrillation
  • Agitation, delirium, confusion, or coma
  • Vomiting, diarrhea, dehydration
  • Jaundice
  • Heart failure, pulmonary edema, hypotension, or shock
If present, diagnose possible thyroid storm and arrange emergency admission and intensive monitoring. Recent systematic reviews on difficult perioperative cases include PMID 39722810, but acute treatment must be directed by an emergency/endocrine team.

Give in such a way that I can solve

Reading File
Finding Sources
Searching PubMed

"Thyrotoxicosis"[MeSH Terms] AND management

Searching the Web

American Thyroid Association guidelines diagnosis management hyperthyroidism thyrotoxicosis

Thyrotoxicosis Syndrome: Clinical Case Sheet for Practice

Patient Case

Name: Ms. R
Age/Sex: 26 years/Female
Occupation: Teacher
Date of admission: __________
Informant: Patient and mother
Reliability: Reliable

Chief Complaints

  1. Palpitations for 2 months
  2. Loss of weight despite increased appetite for 2 months
  3. Excessive sweating and intolerance to heat for 6 weeks
  4. Swelling in the front of neck for 1 month
  5. Prominence of both eyes for 3 weeks

History of Present Illness

The patient was apparently well 2 months ago, after which she developed gradually progressive palpitations. The palpitations are continuous, associated with tremulousness of hands, easy fatigability, anxiety, irritability, and disturbed sleep.
She gives a history of increased appetite but has lost approximately 7 kg in 2 months. She has excessive sweating, heat intolerance, and increased frequency of bowel movements, about 3 to 4 times daily. She reports scanty menstrual flow during the last two cycles.
One month ago, she noticed a painless swelling in the lower anterior neck. It has gradually increased in size. There is no pain, dysphagia, dyspnea, or change of voice.
For the past 3 weeks, she has had prominence of both eyes, excessive tearing, and a gritty sensation in the eyes. There is no diplopia or visual loss.
There is no fever, altered sensorium, vomiting, chest pain, or breathlessness. No history of intake of levothyroxine, amiodarone, lithium, or herbal weight-loss medication.

Past History

  • No known diabetes mellitus, hypertension, bronchial asthma, tuberculosis, or heart disease.
  • No previous thyroid disease.
  • No previous surgery or hospitalization.

Drug and Allergy History

  • No regular medications.
  • No known drug allergy.

Family History

  • Mother has a history of thyroid disease.
  • No family history of thyroid malignancy.

Personal History

HistoryFinding
AppetiteIncreased
DietMixed
BowelIncreased frequency
BladderNormal
SleepDisturbed
Menstrual historyScanty flow for two cycles
Smoking/alcoholNo

Examination Findings

General Physical Examination

ParameterFinding
General conditionConscious, cooperative, anxious-looking
BuildThin
Pulse116/min, regular, high volume
Blood pressure140/60 mmHg
Respiratory rate18/min
TemperatureAfebrile
PallorAbsent
IcterusAbsent
CyanosisAbsent
Pedal edemaAbsent

Additional Findings

  • Warm and moist palms
  • Fine tremor of outstretched hands
  • Hyperreflexia
  • Proximal muscle weakness
  • Fine, soft hair

Thyroid Examination

Inspection

  • Diffuse swelling in the anterior neck.
  • Swelling moves on deglutition.
  • No scar, sinus, or visible veins.

Palpation

  • Thyroid is diffusely enlarged.
  • Soft in consistency.
  • Non-tender.
  • No nodules palpable.
  • Lower border is palpable.
  • No cervical lymphadenopathy.
  • Thrill is present.

Auscultation

  • Bruit is audible over the thyroid gland.

Eye Examination

  • Bilateral lid retraction present
  • Lid lag present
  • Mild bilateral proptosis present
  • Periorbital edema absent
  • Extraocular movements normal
  • No diplopia
  • Visual acuity normal

Systemic Examination

Cardiovascular System

  • Tachycardia present
  • Hyperdynamic precordium
  • S1 and S2 heard
  • No murmur
  • No clinical signs of heart failure

Respiratory System

  • Normal vesicular breath sounds bilaterally
  • No added sounds

Central Nervous System

  • Conscious and oriented
  • Fine tremor and brisk reflexes present
  • No focal neurological deficit

Abdomen

  • Soft and non-tender
  • No hepatosplenomegaly

Investigations

InvestigationResult
TSH<0.01 mIU/L
Free T4Increased
Free T3Increased
TSH receptor antibody, TRAbPositive
Anti-TPO antibodyPositive
CBCNormal
Liver function testNormal
ECGSinus tachycardia
Thyroid ultrasound with DopplerDiffusely enlarged thyroid with increased vascularity
Radioactive iodine uptake scanDiffuse increased uptake

Questions to Solve

  1. What is the syndrome diagnosis in this patient?
  2. What is the most likely etiological diagnosis?
  3. List the clinical features in this case that support your diagnosis.
  4. What is the difference between thyrotoxicosis and hyperthyroidism?
  5. Mention four differential diagnoses of thyrotoxicosis.
  6. Interpret the thyroid function tests.
  7. What is the significance of a positive TRAb result?
  8. What does diffuse increased radioactive iodine uptake indicate?
  9. List the important investigations before starting an antithyroid drug.
  10. Outline the treatment plan for this patient.
  11. Name the three definitive treatment options for Graves disease.
  12. List two serious adverse effects of antithyroid drugs.
  13. What advice should be given if the patient develops fever or sore throat while on an antithyroid drug?
  14. What are the warning features of thyroid storm?
  15. How would the management differ if this patient were pregnant in the first trimester?

Answer Key: Open only after attempting

1. Syndrome diagnosis

Thyrotoxicosis.

2. Etiological diagnosis

Graves disease causing thyrotoxicosis, with diffuse toxic goiter and mild Graves orbitopathy.

3. Features supporting Graves disease

  • Young female patient
  • Palpitations, weight loss, sweating, tremor, heat intolerance, frequent stools
  • Diffuse painless goiter
  • Thyroid bruit and thrill
  • Lid lag, lid retraction, and proptosis
  • Suppressed TSH with raised free T3 and free T4
  • Positive TRAb
  • Diffusely increased radioactive iodine uptake

4. Thyrotoxicosis versus hyperthyroidism

  • Thyrotoxicosis: Clinical syndrome resulting from excess circulating thyroid hormone from any cause.
  • Hyperthyroidism: Excess thyroid hormone production by the thyroid gland itself.
Thus, thyroiditis and excess levothyroxine can cause thyrotoxicosis without true hyperthyroidism.

5. Differential diagnoses

  • Toxic multinodular goiter
  • Toxic adenoma
  • Subacute, painless, or postpartum thyroiditis
  • Factitious thyrotoxicosis due to exogenous thyroid hormone
  • Iodine-induced thyrotoxicosis
  • Amiodarone-induced thyrotoxicosis
  • TSH-secreting pituitary adenoma

6. Interpretation of thyroid function tests

Suppressed TSH with high free T4 and T3 indicates overt primary thyrotoxicosis.

7. Significance of positive TRAb

It supports an autoimmune cause, specifically Graves disease.

8. Significance of diffuse high uptake

It is characteristic of Graves disease. In thyroiditis or exogenous thyroid hormone use, radioactive iodine uptake is low.

9. Baseline investigations before antithyroid drugs

  • Complete blood count with differential count
  • Liver function tests
  • Thyroid function tests
  • Pregnancy test where relevant
  • ECG if significant tachycardia, arrhythmia, or cardiac symptoms

10. Treatment plan

  • Beta-blocker for symptomatic control of tachycardia, tremor, and anxiety, if not contraindicated.
  • Start methimazole/carbimazole as first-line antithyroid treatment in a non-pregnant patient.
  • Monitor free T4, free T3, TSH, clinical symptoms, pulse, and drug adverse effects.
  • Counsel about agranulocytosis and liver injury symptoms.
  • Assess and manage eye disease, including ophthalmology referral if significant.
  • Discuss definitive treatment after achieving euthyroidism.

11. Definitive treatment

  1. Antithyroid drug therapy
  2. Radioactive iodine therapy
  3. Thyroidectomy

12. Serious adverse effects of thionamides

  • Agranulocytosis
  • Hepatotoxicity

13. Advice for fever or sore throat

Stop the antithyroid drug immediately and obtain urgent medical review with a complete blood count to exclude agranulocytosis.

14. Features of thyroid storm

  • High fever
  • Severe tachycardia or atrial fibrillation
  • Agitation, delirium, confusion, seizure, or coma
  • Vomiting, diarrhea, dehydration
  • Heart failure, pulmonary edema, shock
  • Jaundice or severe hepatic dysfunction

15. First-trimester pregnancy

  • PTU is preferred in the first trimester.
  • Radioactive iodine is contraindicated in pregnancy.
  • Management requires close obstetric and endocrinology follow-up.
For exam framing, accurate evaluation includes confirmation of biochemical thyrotoxicosis followed by identifying its cause, as set out in the ATA clinical guidance.
This is a shared conversation. Sign in to Orris to start your own chat.